SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Tunica Albuginea who wrote (5196)2/1/1998 1:05:00 PM
From: RT  Respond to of 23519
 
Tunica,

What would be your best estimate on how soon HVSF can bring their product to market...

I'm still not convinced a liquid would not work satisfactorily.
The one big advantage their product appears to have is that it does not need refrigeration. Six months or longer shelf life without refrigeration is a major marketing advantage. Correct me if I'm wrong.

RT

PS. HVSF closed at 1.06 .



To: Tunica Albuginea who wrote (5196)2/1/1998 4:04:00 PM
From: don roberson  Read Replies (1) | Respond to of 23519
 
TA: did you read the last two new releases on HVSF?? And it is
now over $1. Up 56% friday. per your comment about the HVSF product
being in a liquid form and hard to "manipulate", and "dribbling out".
I thought the VVUS product in pellet form had to be broken down
into solution by mixing with urine. Then the user "massages" to
distribute the compound. Am I incorrect? If true, would the VVUS
product, in mixture with the urine, also have a tendency to "dribble out", and does it not also run the risk of going back into the bladder,
once the pellet starts decomposing.?